November 3, 2016 04:31 PM EDT
R&D

Celyad chief blasts Cel­lec­tis’ CEO Chouli­ka, claim­ing he lied about CAR-T patent

John Carroll

Editor & Founder

Ri­val­ries be­tween biotech CEOs are noth­ing new. But Celyad $CYAD CEO Chris­t­ian Hom­sy took the usu­al spar­ring that oc­ca­sion­al­ly oc­curs be­tween chief ex­ecs to a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Out­look's shares crash as wet AMD drug flunks Phase 3 test

A service from the Financial Times